ELV approaching significant overhead resistance
Elevance Health Inc. (ELV) approaching significant overhead resistance, able to absorb monthly buying pressures.
From here, (ELV) can reject and fall lower to channel support, eliciting losses of 15% - 20% over the following 2 - 3 months.
Inversely, a weekly settlement above resistance would place (ELV) into a buy-signal where gains of 15% - 20% would be expected over the following 2 - 5 months.
From here, (ELV) can reject and fall lower to channel support, eliciting losses of 15% - 20% over the following 2 - 3 months.
Inversely, a weekly settlement above resistance would place (ELV) into a buy-signal where gains of 15% - 20% would be expected over the following 2 - 5 months.
Anthony Speciale, founder of Speciale Analysis offers an affordable approach for all traders to grow into their highest potential.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
Anthony Speciale, founder of Speciale Analysis offers an affordable approach for all traders to grow into their highest potential.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。